Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Filings indexed 1,563 across all filing types
Latest filing 2020-12-02 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
董事会战略委员会实施细则
Governance Information Classification · 95% confidence The document is titled as the implementation rules for the Board of Directors' Strategic Committee of a company. It details the committee's composition, responsibilities, decision-making procedures, meeting rules, and other governance-related matters. There is no financial data, no mention of financial results, no shareholder voting results, no legal proceedings, no capital changes, and no earnings information. The content focuses on internal governance structure and committee rules, which aligns with governance information. The document length is 3239 characters, which is relatively short but contains substantive governance content, not just an announcement or summary. Therefore, the most appropriate classification is Governance Information (CGR).
2020-12-02 Chinese
北京市金杜律师事务所关于公司发行股份购买资产暨关联交易之实施情况的法律意见书
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the implementation of a major asset acquisition transaction by Zhejiang Huatong Pharmaceutical Co., Ltd. It details the issuance of shares to purchase assets, approvals from regulatory bodies including the China Securities Regulatory Commission, the completion of asset transfer and capital verification, and the registration of new shares. The document also discusses board and management changes related to the transaction. The content is focused on the legal and procedural aspects of a capital/financing transaction involving issuance of shares to purchase assets and related approvals. It is not a full annual or interim financial report, nor an earnings release or a general regulatory filing. The document is a detailed legal opinion on the implementation of a capital transaction, which fits the category of Capital/Financing Update (CAP). The document length (7824 characters) and detailed content confirm it is not a mere announcement or certification but a substantive legal opinion on the transaction implementation.
2020-11-26 Chinese
海通证券股份有限公司关于公司发行股份购买资产暨关联交易实施情况之独立财务顾问核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed independent financial advisor's verification opinion regarding a major asset restructuring transaction involving Zhejiang Huatong Pharmaceutical Co., Ltd. It includes extensive information about the transaction scheme, payment methods, asset valuation, performance commitments, procedural compliance, implementation status, and changes in board and senior management. The document is lengthy (15,000 characters) and contains substantive financial and operational details about the transaction and company management changes. It is not merely an announcement or a brief summary but a comprehensive report on the asset purchase and related corporate governance changes. The presence of detailed financial data, audit and valuation reports, and management changes indicates this is a specialized report related to a major asset restructuring and related management information. Given the focus on the asset purchase and related management changes, the best fitting category is "Capital/Financing Update (CAP)" because it covers issuance of shares to purchase assets and related financing activities. The document also includes management changes, but the primary focus is on the financing transaction. Therefore, the classification is CAP with high confidence.
2020-11-26 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 95% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report". It details the changes in shareholding percentages of a major shareholder (浙江绍兴华通商贸集团股份有限公司) in 浙江华通医药股份有限公司, including the background, purpose, and approval procedures of the equity change. The document includes detailed information about the shareholding before and after the transaction, the nature of the equity change (passive dilution due to new shares issued), and compliance with regulatory requirements. It is not a full financial report, earnings release, or management discussion, but a formal notification of a change in major shareholding. This fits the definition of "Major Shareholding Notification (Code: MRQ)". The document length (9469 characters) and content confirm it is the report itself, not just an announcement of a report publication or a certification. Therefore, the classification is MRQ with high confidence.
2020-11-26 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding percentage of an individual shareholder (钱木水) in 浙江华通医药股份有限公司 due to issuance of new shares by the company, resulting in passive dilution of the shareholder's stake. The document includes detailed information about the shareholder, the nature of the equity change, the background of the transaction, approvals obtained, and confirms no active trading by the shareholder in the past 6 months. It is a formal disclosure of a change in shareholding percentage without a change in the number of shares held, consistent with a Major Shareholding Notification. There is no indication that this is a full financial report, earnings release, or management report. It is not a proxy, voting result, or board change announcement. The document is comprehensive and not a brief announcement or certification. Therefore, the best fitting category is Major Shareholding Notification (MRQ).
2020-11-26 Chinese
发行股份购买资产暨关联交易实施情况暨新增股份上市公告书
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the issuance of shares to purchase assets and related party transactions by Zhejiang Huatong Pharmaceutical Co., Ltd. It includes extensive information about the transaction scheme, share issuance price, number of shares, lock-up arrangements, asset valuation, performance commitments, and other related details. The document is titled as an "Implementation Situation and New Shares Listing Announcement" and contains comprehensive data about the transaction and its impact on shareholding and company structure. It is not a simple announcement of a report publication but a full disclosure document with substantive financial and transactional details. The content aligns with a Capital/Financing Update as it deals with issuance of shares, asset purchase, and related capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-11-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.